Toll Free: 1-888-928-9744

Neurosurgical Products - Medical Devices Pipeline Assessment, 2017

Published: Aug 1, 2017 | Pages: 191 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Neurosurgical Products - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Neurosurgical Products - Medical Devices Pipeline Assessment, 2017" provides an overview of Neurosurgical Products currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Neurosurgical Products pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Neurosurgical Products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Neurosurgical Products and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons To Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Neurosurgical Products under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 7 1.2 List of Figures 10 2 Introduction 11 2.1 Neurosurgical Products Overview 11 3 Products under Development 12 3.1 Neurosurgical Products - Pipeline Products by Stage of Development 12 3.2 Neurosurgical Products - Pipeline Products by Segment 13 3.3 Neurosurgical Products - Pipeline Products by Territory 14 3.4 Neurosurgical Products - Pipeline Products by Regulatory Path 15 3.5 Neurosurgical Products - Pipeline Products by Estimated Approval Date 16 3.6 Neurosurgical Products - Ongoing Clinical Trials 17 4 Neurosurgical Products - Pipeline Products under Development by Companies 18 4.1 Neurosurgical Products Companies - Pipeline Products by Stage of Development 18 4.2 Neurosurgical Products - Pipeline Products by Stage of Development 20 5 Neurosurgical Products Companies and Product Overview 22 5.1 Accurexa Inc Company Overview 22 5.1.1 Accurexa Inc Pipeline Products & Ongoing Clinical Trials Overview 22 5.2 Anaconda BioMed SL Company Overview 23 5.2.1 Anaconda BioMed SL Pipeline Products & Ongoing Clinical Trials Overview 23 5.3 Arkis BioSciences Company Overview 24 5.3.1 Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 24 5.4 Augusta University Company Overview 25 5.4.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview 25 5.5 Axion BioSystems Inc Company Overview 26 5.5.1 Axion BioSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 26 5.6 BioArctic AB Company Overview 27 5.6.1 BioArctic AB Pipeline Products & Ongoing Clinical Trials Overview 27 5.7 C2C Development, LLC Company Overview 30 5.7.1 C2C Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 30 5.8 Carl Zeiss Meditec AG Company Overview 31 5.8.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 31 5.9 Carnegie Mellon University Company Overview 32 5.9.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 32 5.10 Carthera SAS Company Overview 33 5.10.1 Carthera SAS Pipeline Products & Ongoing Clinical Trials Overview 33 5.11 Cizeta Surgical Company Overview 37 5.11.1 Cizeta Surgical Pipeline Products & Ongoing Clinical Trials Overview 37 5.12 Cornell University Company Overview 38 5.12.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 38 5.13 DiversiLabs, LLC Company Overview 39 5.13.1 DiversiLabs, LLC Pipeline Products & Ongoing Clinical Trials Overview 39 5.14 Elekta AB Company Overview 40 5.14.1 Elekta AB Pipeline Products & Ongoing Clinical Trials Overview 40 5.15 Hadassah Medical Center Company Overview 41 5.15.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 41 5.16 Integra LifeSciences Holdings Corp Company Overview 42 5.16.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 42 5.17 International HIFU Company Overview 44 5.17.1 International HIFU Pipeline Products & Ongoing Clinical Trials Overview 44 5.18 JetGuide Ltd Company Overview 45 5.18.1 JetGuide Ltd Pipeline Products & Ongoing Clinical Trials Overview 45 5.19 Mayo Clinic US Company Overview 46 5.19.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 46 5.20 Medprin Regenerative Medical Technologies Co Ltd Company Overview 48 5.20.1 Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48 5.21 Medtronic plc Company Overview 49 5.21.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 49 5.22 Monteris Medical Inc Company Overview 53 5.22.1 Monteris Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 53 5.23 MRC Systems GmbH Company Overview 56 5.23.1 MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 56 5.24 MRI Interventions Inc Company Overview 57 5.24.1 MRI Interventions Inc Pipeline Products & Ongoing Clinical Trials Overview 57 5.25 NICO Corporation Company Overview 59 5.25.1 NICO Corporation Pipeline Products & Ongoing Clinical Trials Overview 59 5.26 Optiscan Imaging Limited Company Overview 60 5.26.1 Optiscan Imaging Limited Pipeline Products & Ongoing Clinical Trials Overview 60 5.27 PediaWorks Inc Company Overview 62 5.27.1 PediaWorks Inc Pipeline Products & Ongoing Clinical Trials Overview 62 5.28 Replication Medical Inc Company Overview 63 5.28.1 Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 63 5.29 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 64 5.29.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 64 5.30 StereoTools SA Company Overview 65 5.30.1 StereoTools SA Pipeline Products & Ongoing Clinical Trials Overview 65 5.31 The Swedish Neuroscience Institute Company Overview 66 5.31.1 The Swedish Neuroscience Institute Pipeline Products & Ongoing Clinical Trials Overview 66 5.32 The University of Utah Company Overview 67 5.32.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 67 5.33 University of California San Francisco Company Overview 69 5.33.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 69 5.34 University of Colorado Company Overview 70 5.34.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 70 5.35 University of Maryland Baltimore Company Overview 71 5.35.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 71 5.36 University of South Florida Company Overview 72 5.36.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 72 5.37 University of Texas Medical Branch at Galveston Company Overview 73 5.37.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 73 5.38 Vanderbilt University Company Overview 74 5.38.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 74 5.39 Xylos Corporation Company Overview 76 5.39.1 Xylos Corporation Pipeline Products & Ongoing Clinical Trials Overview 76 6 Neurosurgical Products- Recent Developments 77 6.1 Jul 27, 2017: High Interest In Early Removal Of Hemorrhagic Stroke Leads To Doubling Number Of Clinical Trial Sites 77 6.2 Jul 27, 2017: Stryker reports second quarter 2017 results 77 6.3 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 78 6.4 Jul 11, 2017: MRI Interventions Announces Record Second Quarter ClearPoint System Procedures, And a 79% Year-Over-Year Revenue Increase 80 6.5 Jul 05, 2017: Penumbra Promotes Daniel Davis to Chief Commercial Officer 80 6.6 Jun 28, 2017: Parkinson's Disease Patients are First to be Treated With Elekta's New Leksell Vantage Stereotactic System 81 6.7 Jun 12, 2017: Carevature Medical Announces Pioneering Cervical Spinal Decompressions in the US 82 6.8 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 82 6.9 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 83 6.10 May 23, 2017: Brainlab Chief Financial Officer Joseph Doyle to Retire 86 6.11 May 18, 2017: Renishaw presents implant technology for oral and maxillofacial surgeons 86 6.12 May 17, 2017: Sperling Medical Successfully Treats First Florida Tremor Cases 87 6.13 May 15, 2017: American Shared Hospital Services Reports Higher First Quarter Revenue and Net Income 88 6.14 May 11, 2017: Healthcare Veteran John Fletcher Joins MRI Interventions' Board of Directors 89 6.15 May 11, 2017: ZEISS: Significant Growth in Revenue and Earnings 90 6.16 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 91 6.17 May 09, 2017: INSIGHTEC Receives FDA Approval for Exablate Neuro for 1.5T MRI in the Treatment of Essential Tremor 92 6.18 May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results 92 6.19 May 08, 2017: ZEISS Appoints New Fellow 93 6.20 May 02, 2017: Misonix Reports Third Quarter Fiscal Year 2017 Financial Results 94 6.21 May 02, 2017: Brainlab Names New Member of Executive Board 94 6.22 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017 95 6.23 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results 96 6.24 Apr 27, 2017: MRI Interventions Announces 2017 First Quarter Results 97 6.25 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 99 6.26 Apr 25, 2017: The All-new Robotic Visualization System KINEVO 900 from ZEISS Revolutionizes Neurosurgical Visualization 101 6.27 Apr 25, 2017: Stryker reports first quarter 2017 results 102 6.28 Apr 24, 2017: Anaconda Biomed Engages Creganna Medical 103 6.29 Apr 24, 2017: Elekta to Highlight Continued Innovation in Stereotactic Neurosurgery with Leksell Vantage Stereotactic System at AANS 104 6.30 Apr 24, 2017: Precision Intratumoral Delivery of DNX-2401 with the Alcyone MEMS Cannula 105 6.31 Apr 23, 2017: Bard Announces First Quarter Results 106 6.32 Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors 106 6.33 Apr 20, 2017: Insightec: First Patient With Benign Brain Tumor has Focused Ultrasound Procedure at Nicklaus Children's Hospital 107 6.34 Apr 20, 2017: Lysogene Announces Selection of MRI Interventions' SmartFlow Cannula for Phase II/III Clinical Study in MPS IIIA 108 6.35 Apr 20, 2017: Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire Technology 108 6.36 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years 109 6.37 Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter 109 6.38 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 110 6.39 Apr 03, 2017: NICO Announces CE Mark for BrainPath Non-Disruptive Cranial Access Technology 110 6.40 Mar 23, 2017: American Shared Hospital Services Fourth Quarter Net Income Increased 63.2% as Revenue Increased 21.6% 111 6.41 Mar 21, 2017: Dieter Kurz Confirmed as Chairman of the Supervisory Boards at SCHOTT and ZEISS 113 6.42 Mar 20, 2017: Acera Surgical Receives FDA Clearance for Nanofabricated Tissue Scaffold 113 6.43 Mar 16, 2017: Integra LifeSciences Introduces Next Generation CUSA Clarity Ultrasonic Tissue Ablation System 114 6.44 Mar 13, 2017: Misonix Announces Second Quarters of Fiscal 2017 114 6.45 Mar 13, 2017: Misonix Files Forms 10-Q for First and Second Quarters of Fiscal 2017 115 6.46 Mar 10, 2017: IMRIS, Deerfield Imaging appoints Robert C. Korn as Senior Vice President - Global Sales and Marketing 116 6.47 Feb 28, 2017: MRI Interventions Announces 2016 Fourth Quarter and Full Year Results 117 6.48 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results 120 6.49 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth 121 6.50 Feb 23, 2017: Avella Specialty Pharmacy recall sterile products produced at Advanced Pharma Houston Location from September 1, 2016 through February 16, 2017 Due to Potential Inaccuracy of Latex Free Label Reference 124 6.51 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 124 6.52 Feb 23, 2017: Renishaw exhibiting at BioWales 2017 126 6.53 Feb 22, 2017: Top Academic Healthcare Centers Presenting New Surgical Options for Stroke Patients 126 6.54 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 127 6.55 Feb 20, 2017: ACERA Selected as One of the “Best University Startups 2016” by National Council of Entrepreneurial Tech Transfer 130 6.56 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 130 6.57 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 131 6.58 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 133 6.59 Jan 31, 2017: FDA Grants New Clearance for Brain Surgery Technology 133 6.60 Jan 26, 2017: Bard Announces Fourth Quarter Results 134 6.61 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer 135 6.62 Jan 24, 2017: First Procedure Performed in Medtronic MRI-Guided Laser Ablation Trial to Treat Common Form of Epilepsy 136 6.63 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 137 6.64 Jan 24, 2017: MRI Interventions Announces Year-End Update, Including 2016 Fourth Quarter and Full Year Revenues 138 6.65 Jan 23, 2017: 7D Surgical Receives FDA 510(K) and Health Canada MDL Clearance for Its Breakthrough Image Guidance System for Spine Surgery 139 6.66 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board 140 6.67 Jan 10, 2017: NICO Announces First Patient Enrolled in Phase 3 Randomized Controlled Trial on Early Intervention of Hemorrhagic Stroke, Deadliest Form of Stroke 140 6.68 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 141 6.69 Jan 09, 2017: Anaconda BioMed Appoints Mr. Giovanni Leo to its Advisory Board 143 6.70 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia 143 7 Appendix 188 7.1 Methodology 188 7.2 About GlobalData 191 7.3 Contact Us 191 7.4 Disclaimer 191
List of Tables
Table 1: Neurosurgical Products - Pipeline Products by Stage of Development 12 Table 2: Neurosurgical Products - Pipeline Products by Segment 13 Table 3: Neurosurgical Products - Pipeline Products by Territory 14 Table 4: Neurosurgical Products - Pipeline Products by Regulatory Path 15 Table 5: Neurosurgical Products - Pipeline Products by Estimated Approval Date 16 Table 6: Neurosurgical Products - Ongoing Clinical Trials 17 Table 7: Neurosurgical Products Companies - Pipeline Products by Stage of Development 18 Table 8: Neurosurgical Products - Pipeline Products by Stage of Development 20 Table 9: Accurexa Inc Pipeline Products & Ongoing Clinical Trials Overview 22 Table 10: BranchPoint Device - Product Status 22 Table 11: BranchPoint Device - Product Description 22 Table 12: Anaconda BioMed SL Pipeline Products & Ongoing Clinical Trials Overview 23 Table 13: ANCD BRAIN - Product Status 23 Table 14: ANCD BRAIN - Product Description 23 Table 15: Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 24 Table 16: CerebroFlo - Product Status 24 Table 17: CerebroFlo - Product Description 24 Table 18: Augusta University Pipeline Products & Ongoing Clinical Trials Overview 25 Table 19: Surgical Instrument - Neurological Procedures - Product Status 25 Table 20: Surgical Instrument - Neurological Procedures - Product Description 25 Table 21: Axion BioSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 26 Table 22: Microhook Based Nerve Tape Device - Product Status 26 Table 23: Microhook Based Nerve Tape Device - Product Description 26 Table 24: BioArctic AB Pipeline Products & Ongoing Clinical Trials Overview 27 Table 25: Spinal Cord Injury FGF1/Device SC0806 - Product Status 27 Table 26: Spinal Cord Injury FGF1/Device SC0806 - Product Description 27 Table 27: BioArctic AB - Ongoing Clinical Trials Overview 28 Table 28: Spinal Cord Injury FGF1/Device SC0806 - An Open, Randomized, Rehabilitation-controlled Study to Assess Safety, Tolerability, and Efficacy of Heparin Activated Recombinant Fibroblast Growth Factor 1 on a Biodegradable Device in Subjects with Traumatic Spinal Cord Injury 29 Table 29: C2C Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 30 Table 30: NAViTECH Streamlined Device - Product Status 30 Table 31: NAViTECH Streamlined Device - Product Description 30 Table 32: Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 31 Table 33: QEVO - Product Status 31 Table 34: QEVO - Product Description 31 Table 35: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 32 Table 36: Hydrosurgery System - Product Status 32 Table 37: Hydrosurgery System - Product Description 32 Table 38: Carthera SAS Pipeline Products & Ongoing Clinical Trials Overview 33 Table 39: SonoCloud - Product Status 33 Table 40: SonoCloud - Product Description 33 Table 41: SonoProbe - Product Status 34 Table 42: SonoProbe - Product Description 34 Table 43: Carthera SAS - Ongoing Clinical Trials Overview 35 Table 44: SonoCloud - A Study to Evaluate the Safety of Transient Opening of the Blood-brain Barrier by Low Intensity Pulsed Ultrasound with the SonoCloud Implantable Device in Patients with Recurrent Glioblastoma Before Chemotherapy Administration 36 Table 45: Cizeta Surgical Pipeline Products & Ongoing Clinical Trials Overview 37 Table 46: SKULL GRIP - Product Status 37 Table 47: SKULL GRIP - Product Description 37 Table 48: Cornell University Pipeline Products & Ongoing Clinical Trials Overview 38 Table 49: Tightly-Focused Femtosecond Laser - Product Status 38 Table 50: Tightly-Focused Femtosecond Laser - Product Description 38 Table 51: DiversiLabs, LLC Pipeline Products & Ongoing Clinical Trials Overview 39 Table 52: SAlinac System - Product Status 39 Table 53: SAlinac System - Product Description 39 Table 54: Elekta AB Pipeline Products & Ongoing Clinical Trials Overview 40 Table 55: Leksell Vantage Stereotactic System - Product Status 40 Table 56: Leksell Vantage Stereotactic System - Product Description 40 Table 57: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 41 Table 58: MIFUS Device - Product Status 41 Table 59: MIFUS Device - Product Description 41 Table 60: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 42 Table 61: Cranial Access Kit - Product Status 42 Table 62: Cranial Access Kit - Product Description 42 Table 63: MAYFIELD Composite - Product Status 43 Table 64: MAYFIELD Composite - Product Description 43 Table 65: Stereotaxy Device - Product Status 43 Table 66: Stereotaxy Device - Product Description 43 Table 67: International HIFU Pipeline Products & Ongoing Clinical Trials Overview 44 Table 68: Focused Ultrasound System - Product Status 44 Table 69: Focused Ultrasound System - Product Description 44 Table 70: JetGuide Ltd Pipeline Products & Ongoing Clinical Trials Overview 45 Table 71: JetGuide System - Neuro - Product Status 45 Table 72: JetGuide System - Neuro - Product Description 45 Table 73: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 46 Table 74: Minimally Invasive Neurology/Neurosurgery Device - Product Status 46 Table 75: Minimally Invasive Neurology/Neurosurgery Device - Product Description 46 Table 76: Stereotactic-Guided Laser Ablation System - Product Status 47 Table 77: Stereotactic-Guided Laser Ablation System - Product Description 47 Table 78: Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48 Table 79: Recranio - Product Status 48 Table 80: Recranio - Product Description 48 Table 81: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 49 Table 82: Stealth Station S8 - Product Status 49 Table 83: Stealth Station S8 - Product Description 49 Table 84: Visualase System - Epilepsy - Product Status 50 Table 85: Visualase System - Epilepsy - Product Description 50 Table 86: Medtronic plc - Ongoing Clinical Trials Overview 51 Table 87: Visualase System - Epilepsy - Stereotactic Laser Ablation for Temporal Lobe Epilepsy 52 Table 88: Monteris Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 53 Table 89: NeuroBlate System - Medically Refractory Epilepsy - Product Status 53 Table 90: NeuroBlate System - Medically Refractory Epilepsy - Product Description 53 Table 91: Monteris Medical Inc - Ongoing Clinical Trials Overview 54 Table 92: NeuroBlate System - Medically Refractory Epilepsy - Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy: FLARE 55 Table 93: MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 56 Table 94: Multilas - Product Status 56 Table 95: Multilas - Product Description 56 Table 96: MRI Interventions Inc Pipeline Products & Ongoing Clinical Trials Overview 57 Table 97: ClearPoint Electrode Placement Device - Alzheimer's Disease - Product Status 57 Table 98: ClearPoint Electrode Placement Device - Alzheimer's Disease - Product Description 58 Table 99: ClearPoint Electrode Placement Device - Severe Depression - Product Status 58 Table 100: ClearPoint Electrode Placement Device - Severe Depression - Product Description 58 Table 101: NICO Corporation Pipeline Products & Ongoing Clinical Trials Overview 59 Table 102: Neurosurgery Device - Glioblastoma Multiforme - Product Status 59 Table 103: Neurosurgery Device - Glioblastoma Multiforme - Product Description 59 Table 104: Optiscan Imaging Limited Pipeline Products & Ongoing Clinical Trials Overview 60 Table 105: Neurosurgical Endomicroscopy System - Product Status 60 Table 106: Neurosurgical Endomicroscopy System - Product Description 61 Table 107: PediaWorks Inc Pipeline Products & Ongoing Clinical Trials Overview 62 Table 108: Neurosurgery Resector - Product Status 62 Table 109: Neurosurgery Resector - Product Description 62 Table 110: Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 63 Table 111: Neural Implant - Product Status 63 Table 112: Neural Implant - Product Description 63 Table 113: Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 64 Table 114: Craniotomy Suture Passer - Product Status 64 Table 115: Craniotomy Suture Passer - Product Description 64 Table 116: StereoTools SA Pipeline Products & Ongoing Clinical Trials Overview 65 Table 117: StereoPod - Product Status 65 Table 118: StereoPod - Product Description 65 Table 119: The Swedish Neuroscience Institute Pipeline Products & Ongoing Clinical Trials Overview 66 Table 120: MR-guided Focused Ultrasound System - Product Status 66 Table 121: MR-guided Focused Ultrasound System - Product Description 66 Table 122: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 67 Table 123: Computer-Controlled Surgical Cutting Tool - Product Status 67 Table 124: Computer-Controlled Surgical Cutting Tool - Product Description 67 Table 125: Hollow Artificial Conduit - Product Status 68 Table 126: Hollow Artificial Conduit - Product Description 68 Table 127: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 69 Table 128: Stereotactic Insertion Guidance System - Product Status 69 Table 129: Stereotactic Insertion Guidance System - Product Description 69 Table 130: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 70 Table 131: Denver Surgical Corridor - Product Status 70 Table 132: Denver Surgical Corridor - Product Description 70 Table 133: University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 71 Table 134: Minimally Invasive Neurosurgical Intracranial Robot - Product Status 71 Table 135: Minimally Invasive Neurosurgical Intracranial Robot - Product Description 71 Table 136: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 72 Table 137: Dural Knife With Protective Foot-Plate - Product Status 72 Table 138: Dural Knife With Protective Foot-Plate - Product Description 72 Table 139: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 73 Table 140: Endoscope With Stimulating Electrode - Product Status 73 Table 141: Endoscope With Stimulating Electrode - Product Description 73 Table 142: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 74 Table 143: Flat-Cut Bit For Cranial Perforator - Product Status 74 Table 144: Flat-Cut Bit For Cranial Perforator - Product Description 74 Table 145: PosiSeat - Product Status 75 Table 146: PosiSeat - Product Description 75 Table 147: Xylos Corporation Pipeline Products & Ongoing Clinical Trials Overview 76 Table 148: Dura Replacement Device - Product Status 76 Table 149: Dura Replacement Device - Product Description 76 Table 150: Glossary 190


List of Figures
Figure 1: Neurosurgical Products - Pipeline Products by Stage of Development 12 Figure 2: Neurosurgical Products - Pipeline Products by Segment 13 Figure 3: Neurosurgical Products - Pipeline Products by Territory 14 Figure 4: Neurosurgical Products - Pipeline Products by Regulatory Path 15 Figure 5: Neurosurgical Products - Pipeline Products by Estimated Approval Date 16 Figure 6: Neurosurgical Products - Ongoing Clinical Trials 17

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global microcontroller market is estimated to be valued at USD 26.9 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing demand in key application areas such as automotive, consumer electronics and healthcare is expected to

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...
Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify